Kim Kamdar
Managing Partner at Medical Excellence Capital
About
PhD researcher with 17+ years of experience in therapeutic start-ups and personalized medicine diagnostics. She has been instrumental in creating and serving on boards of numerous biotech companies, including several that achieved significant exits (Ariosa to Roche for $625M, Omniome to Pacific Biosciences for $800M). She has been a partner at Domain Associates since 2010.
Colleagues at Medical Excellence Capital
Annabel Stoddart
Office Manager and Executive Assistant at Medical Excellence Capital
Brad Ringeisen
Scientific Advisory Board – Executive Director of Innovative Genomics Institute at Medical Excellence Capital
Brian Halak
Managing Partner at Medical Excellence Capital
Douglas C Wallace
Scientific Advisory Board – Director of Center for Mitochondrial and Epigenomic Medicine at Medical Excellence Capital
Eric Heil
Managing Partner at Medical Excellence Capital
Gregg L. Semenza
Scientific Advisory Board – Professor at Johns Hopkins at Medical Excellence Capital
John P. Hornbostel
Counsel at Medical Excellence Capital
John Prufeta
Chief Executive Officer and Managing Partner at Medical Excellence Capital